SCHEMBL3696263

SCHEMBL3696263

CCOC(=O)C1CC1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8166437 1.00 — —
SCHEMBL7198390 1.00 — —
SCHEMBL25144056 0.95 CA1 (0.41) —
SCHEMBL25144499 0.88 CA1 (0.37) —
SCHEMBL25144280 0.88 CA1 (0.37) —
SCHEMBL8914013 0.85 ALDH1A1 (0.48) —
SCHEMBL12943060 0.85 ALDH1A1 (0.48) —
SCHEMBL2705849 0.85 ALDH1A1 (0.48) —
SCHEMBL2705851 0.85 ALDH1A1 (0.48) —
SCHEMBL1296897 0.85 ALDH1A1 (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8092186-A — — None — — JP disclosed
CN-119504397-A Synthesis method of 2-fluorocyclopropane carboxylic acid 上海裕兰生物科技有限公司 2025-02-25 — — CN disclosed
EP-3541804-B1 CYCLOALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2025-01-22 — — EP disclosed
CN-114380820-A Hetero-fused ring derivative and application thereof in medicine 海思科医药集团股份有限公司 2022-04-22 — — CN disclosed
US-11020395-B2 Cycloalkyl substituted triazole compounds as agonists of the APJ receptor AMGEN INC. (US) 2021-06-01 — — US disclosed
US-20190290648-A1 CYCLOALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2019-09-26 — — US disclosed
EP-1792889-B1 Process for the preparation of carboxylic acid esters SUMITOMO CHEMICAL CO (JP) 2015-03-04 — — EP disclosed
EP-2794605-A1 2, 4-DIAMINE-PYRIMIDINE DERIVATIVE AS SERINE/THREONINE KINASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2014-10-29 — — EP disclosed
EP-1731499-B1 PROCESS FOR PRODUCING 1,2-CIS-2-FLUOROCYCLOPROPANE-1-CARBOXYLIC ESTER COMPOUND DAIICHI SANKYO CO LTD (JP) 2014-10-01 — — EP disclosed
EP-2748159-A1 SERINE/THREONINE PAK1 INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2014-07-02 — — EP disclosed
US-20050113581-A1 Process for the preparation of carboxylic acid esters SUMITOMO CHEMICAL COMPANY, LIMITED 2005-05-26 — — US disclosed
US-6596898-B2 Making a 2-fluoro-2-chlorocyclopropanecarboxylic acid derivative stereoselectively in high yield by reacting a diazoacetic acid derivative with 1-fluoro-1-chloroethylene using metal catalyst having chiral ligands DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-07-22 — — US disclosed
US-20010051750-A1 PROCESS FOR PREPARING HALOGENATED CYCLOPROPANE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-12-13 — — US disclosed
EP-0858992-B1 PROCESS FOR PRODUCING HALOGENATED CYCLOPROPANE DERIVATIVES DAIICHI SEIYAKU CO (JP) 2001-12-12 — — EP disclosed
US-6130350-A Process for producing 2-fluorine-1-cyclopropane carboxylic acid derivatives by reductive dehalogenation BAYER AKTIENGESELLSCHAFT (DE) 2000-10-10 — — US disclosed
EP-0712831-B1 SELECTIVE DEHALOGENATION METHOD DAIICHI SEIYAKU CO (JP) 1999-11-03 — — EP disclosed
EP-0858992-A1 PROCESS FOR PRODUCING HALOGENATED CYCLOPROPANE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-08-19 — — EP disclosed
US-5780669-A Selective dehalogenation process DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-07-14 — — US disclosed
EP-0712831-A1 SELECTIVE DEHALOGENATION METHOD DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1996-05-22 — — EP disclosed
JP-H0892186-A PRODUCTION OF OPTICALLY ACTIVE CIS-2-FLUOROCYCLOPROPANECARBOHYDRAZIDE SUMITOMO CHEM CO LTD 1996-04-09 — — JP disclosed
Send feedback